🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the safety, tolerability, pharmacokinetics, and effica...
Status
Terminated
Location
Malawi-Liverpool-Wellcome Trust Clinical Research Programme (MLW)
Start Date
2017-12-14
Trial ID
NCT03341767
Treatments Being Tested
The purpose of this study was to evaluate the pharmacokinetic (PK) properti...
Status
Terminated
Location
Usc La Nichd Crs
Start Date
2021-09-01
Trial ID
NCT04518228
Treatments Being Tested
The purpose of the study was to evaluate the efficacy (how well the medicin...
Status
Completed
Location
Gaborone CRS (Site ID: 12701)
Start Date
2022-09-27
Trial ID
NCT05007821
The purpose of this randomized trial is to verify if leprosy patients, desp...
Status
Completed
Location
Centro de Referência Nacional Alfredo da Matta - FUAM
Start Date
2007-02
Trial ID
NCT00669643
The purpose of this study is to explore safety and efficacy of TMC207 admin...
Status
Completed
Location
Multiple Locations
Start Date
2015-02-18
Trial ID
NCT02365623
Treatments Being Tested
Clofazimine (CFZ) is a promising drug for the treatment of NTM diseases. CF...
Status
Completed
Location
Radboud university medical center
Start Date
2022-02-14
Trial ID
NCT05294146
Treatments Being Tested
Lamprene®/Clofazimine, is a product of the pharmaceutical company named Nov...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04334070
Treatments Being Tested
The purpose of this study is to assess the efficacy, safety and tolerabilit...
Status
Completed
Location
The Third People's Hospital of Shenzhen City
Start Date
2021-01-20
Trial ID
NCT04717908
Treatments Being Tested
The purpose of this study was to compare a 3-month rifapentine (RPT)/clofaz...
Status
Terminated
Location
Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS
Start Date
2021-11-05
Trial ID
NCT04311502
The purpose of this study is to assess the efficacy, safety and tolerabilit...
Status
Completed
Location
The Third People's Hospital of Shenzhen City
Start Date
2020-06-01
Trial ID
NCT03867136
Treatments Being Tested